Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anakinra for Dengue Patients With Hyperinflammation - a Randomized Double-blind Placebo-controlled Trial

NCT05611710 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit, Vietnam as lead sponsor.

NCT NCT05611710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anakinra for Dengue Patients With Hyperinflammation - a Randomized Double-blind Placebo-controlled Trial
Lead sponsor
Oxford University Clinical Research Unit, Vietnam
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 2, 2023
Completion date
December 31, 2027
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anakinra, anti-inflammatory agents, cytokine storm, dengue, dengue with warning signs, hyperinflammatory syndrome, immuno-modulation, macrophage activation syndrome, severe dengue